[MO40-3] Oncogenic mutation count as a prognostic predictor of 1st line pembrolizumab for PD-L1-positive NSCLC
Abstract password authentication.
The password can be found on page 27 of the program book.
Mini-Oral Session
Sat. Feb 19, 2022 2:55 PM - 3:45 PM Room 11 (Prince Hall 1, B2F, The Prince Kyoto Takaragaike)
Chair:Naoko Aragane(Department of Respiratory Medicine, Saga University Hospital),Takayasu Kurata(Department of Thoracic Oncology, Kansai Medical University Hospital)
Abstract password authentication.
The password can be found on page 27 of the program book.